Tech Acquisitions and Earnings Boost: Key Stocks on the Rise

Generated by AI AgentAinvest Market Brief
Wednesday, Jul 17, 2024 6:30 pm ET1min read
GAN--
GFS--
PGR--
1. Globalfoundries (Unknown code: GFS)
Globalfoundries surged by 6.82%. Globalfoundries acquired GaN technology and IP from Tagore Technology to enhance efficiency and performance in automotive, IoT, and AI data centers. Cantor Fitzgerald reiterated its Neutral rating with a target price of $55.

2. The Progressive (NYSE: PGR)
The Progressive gained solidly by 5.42%. The Progressive reported Q1 2024 revenue of $17.243 billion, a 20.55% increase year-over-year. B of A Securities maintains a "Buy" rating with a latest target price of $293.00. JP Morgan maintains "Overweight" with a target price of $239.00. Keefe, Bruyette & Woods upgraded to "Outperform" with a target price of $245.00.

3. Bristol-Myers Squibbmpany (NYSE: BMY)
Bristol-Myers Squibbmpany gained solidly by 4.77%. Bristol-Myers Squibb has submitted a new indication application for its PD-1 inhibitor nivolumab in China. Barclays maintains its rating on the company as Equal-Weight with a new price target of $41.00.

4. U.S. Bancorp (NYSE: USB)
U.S. Bancorp gained solidly by 4.55%. U.S. Bancorp will announce its Q2 2024 financial results on July 17. Jefferies maintains a Hold rating, lowering its price target to $42. JP Morgan downgrades to Neutral with a $43.50 target. Evercore ISI rates In-Line, raising the target to $48.

5. Unitedhealth Group Incorporated (NYSE: UNH)
Unitedhealth Group Incorporated gained solidly by 4.43%. UnitedHealth Group reported second-quarter 2024 earnings, with revenue of $1986.51 billion, net income of $32 billion, and EPS of $3.05. Morgan Stanley, Jefferies, and Baird adjusted ratings and targets, with Morgan Stanley at $615, Jefferies at $647, and Baird at $640.

Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet